JACC Podcast

1719 Folgen

1. Acoramidis and Early sTTR Rise: Biomarker-Driven Insights into Survival | JACC Baran

   Vom: 27.5.2025
2. June 3, 2025 Issue Summary | JACC

   Vom: 27.5.2025
3. Insights From the INTERASPIRE Study | JACC Deep Dive

   Vom: 27.5.2025
4. SORT OUT XI | EuroPCR.25 | JACC

   Vom: 21.5.2025
5. VT Prevention in Repaired Tetralogy of Fallot: Mapping SCAI and Minimizing ICDs | JACC Baran

   Vom: 20.5.2025
6. Vutrisiran Impact on Functional Capacity and QOL | JACC Deep Dive | JACC

   Vom: 20.5.2025
7. May 27, 2025 Issue Summary | JACC

   Vom: 19.5.2025
8. 10 Year Outcome of DANAMI 3 PRIMULTI | JACC | EuroPCR.25 | JACC

   Vom: 19.5.2025
9. Vutrisiran and Mortality in ATTR-CM | JACC | ESCHF25

   Vom: 17.5.2025
10. Rethinking Rehab: ACTIVE-ADHF and the Power of Early Intervention | JACC Baran

    Vom: 13.5.2025
11. Individual Variation in Tirzepatide Response | JACC Deep Dive

    Vom: 13.5.2025
12. JACC Editor's Page: March 18, 2025 | JACC

    Vom: 12.5.2025
13. May 20, 2025 Issue Summary | JACC

    Vom: 12.5.2025
14. Altshock-2 Through a Regional Lens: IABP in HF-CS | JACC Baran

    Vom: 6.5.2025
15. Revisiting the SUMMIT Trial | JACC Deep Dive

    Vom: 6.5.2025
16. Disentangling the Impact of Adiposity From Insulin Resistance in HFpEF | JACC Deep Dive

    Vom: 6.5.2025
17. May 13, 2025 Issue Summary | JACC

    Vom: 5.5.2025
18. JACC Editor's Page: May 13, 2025

    Vom: 5.5.2025
19. Ischemia on Dobutamine Stress Echocardiography Predicts Efficacy of PCI: Results from ORBITA-2 | JACC

    Vom: 5.5.2025
20. Interplay of Chronic Kidney Disease and the Effects of Tirzepatide in Patients With Heart Failure, Preserved Ejection Fraction and Obesity: the SUMMIT Trial | JACC

    Vom: 5.5.2025